My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 911

    1.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Kidney Int. 2002 Jul;62(1):192-8.PMID: 12081578 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.

    Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T.

    Nephron. 1998 Sep;80(1):17-24.PMID: 9730698 [PubMed - indexed for MEDLINE]Related articles

    4.

    Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.

    Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH.

    Scand J Clin Lab Invest. 2006;66(3):173-80.PMID: 16714246 [PubMed - indexed for MEDLINE]Related articles

    5.

    Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.

    Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS.

    Diabetes Care. 1998 Mar;21(3):431-7.PMID: 9540028 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.

    Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH.

    Kidney Int. 1998 Apr;53(4):1002-6.PMID: 9551410 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.

    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.

    BMJ. 1996 Sep 7;313(7057):591-4.PMID: 8806248 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.

    Björck S, Blohmé G, Sylvén C, Mulec H.

    Nephrol Dial Transplant. 1997;12 Suppl 2:67-70.PMID: 9269704 [PubMed - indexed for MEDLINE]Related articles

    9.

    Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

    Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.

    Diabetologia. 2004 Nov;47(11):1936-9. Epub 2004 Nov 17.PMID: 15551047 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.

    Park HC, Choi HY, Kim BS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.

    Kidney Blood Press Res. 2006;29(4):216-24. Epub 2006 Sep 8.PMID: 16960460 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.

    Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K.

    Diabetologia. 1995 Jul;38(7):798-803.PMID: 7556981 [PubMed - indexed for MEDLINE]Related articles

    12.

    Progression of diabetic nephropathy in normotensive type 1 diabetic patients.

    Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.

    Kidney Int Suppl. 1999 Jul;71:S101-5.PMID: 10412749 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.

    Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M, Luong LA, Fuller JH.

    Diabetes. 1998 Sep;47(9):1507-11.PMID: 9726242 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.

    Rudberg S, Rasmussen LM, Bangstad HJ, Osterby R.

    Diabetes Care. 2000 Apr;23(4):544-8.PMID: 10857950 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients.

    Lee YJ, Tsai JC.

    Diabetes Care. 2002 Jun;25(6):1002-8.PMID: 12032106 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Optimal dose of losartan for renoprotection in diabetic nephropathy.

    Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH.

    Nephrol Dial Transplant. 2002 Aug;17(8):1413-8.PMID: 12147788 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.

    Kidney Int. 2000 Feb;57(2):601-6.PMID: 10652037 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors]

    Tarnow L, Parving HH, Jacobsen P, Rossing P, Lecerf L, Poirier O, Cambien F.

    Ugeskr Laeger. 1998 Aug 17;160(34):4886-9. Danish. PMID: 9741257 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

    Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

    Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity